Both in vitro and in vivo experiments conducted on pancreatic cancer (PC) cell lines have further concluded that MAPK signaling serves as a key regulator of PD-L1 expression in the tumor microenvironment [69]. This evidence concerns the gene CD274 and pachyonychia congenita.